{"id":"W4312018944","doi":"10.1016/j.annonc.2022.12.007","title":"Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University of British Columbia","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Chemotherapy; Docetaxel; Population; Capecitabine; Gemcitabine; Cancer; Surgery; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001470759,0.0003204632,0.002606358,0.0002769585,0.0001713633,0.00001449298,0.0003878766,0.00009698943,0.002458337],"category_scores_gemma":[0.0002027984,0.0002499907,0.0001442673,0.0005183053,0.0002291073,0.0001581128,0.0001561587,0.0004493928,0.000003362716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003071316,"about_ca_system_score_gemma":0.001333408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001853103,"about_ca_topic_score_gemma":0.001113413,"domain_scores_codex":[0.9966274,0.0009124696,0.001009127,0.0005343251,0.0003971232,0.0005195304],"domain_scores_gemma":[0.9979773,0.0008389225,0.0004684246,0.00037097,0.000159551,0.0001848631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7795122,0.009468825,0.00001095078,0.00003562373,0.0008045095,0.0001796971,0.002500204,0.00001307156,0.0004389554,0.00007817528,0.005793383,0.2011644],"study_design_scores_gemma":[0.889946,0.07577067,0.00001824115,0.0000534148,0.0001966666,0.00002223164,0.0005071133,0.0007553214,0.0006948264,0.0001080087,0.03171011,0.0002173361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788854,0.005609783,0.000008667032,0.007230759,0.001298418,0.003874039,0.0001405058,0.00003830171,0.002914092],"genre_scores_gemma":[0.9746123,0.01561153,0.0004844921,0.004682336,0.0003467402,0.003323425,0.0001050231,0.00007125312,0.0007629318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.200947,"threshold_uncertainty_score":0.9999952,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2366118768115211,"score_gpt":0.5025671330450882,"score_spread":0.2659552562335671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}